- - -839FD1937722
UUIDzE'IZFCASS-BDZS 4855 9325 R d ted

 

TCGA-YE-ASSl-OlA-PR e ac
IllIllllllllllllllllllllllll|I|||||l| lllllllllll|||l||||||lllllll .—
llllllllllllllllllllllllllllllllllll
. lI‘l‘l‘lmm‘l‘l‘lilil‘l‘li‘l'll‘llllllllllllllllllllllllllllllllll ZCZD-o- 3
. . Won/Mb, fair/3% W1
Research Gross Description $201513

- male with renal lesion_

Research Dx 6‘11 3 ® #3 ) “bail/.9

Left lower pole renal mass. partial nephrectomy:
Papillary carcinoma, Type 2, cystic. 9%.) MI 7/ l 9
Small cortical adenoma.

CASE SUMMARY FOR NEPHRECTOMY FOR RENAL CELL CARCINOMA:

Procedure: Partial nephrectomy
Specimen laterality: Left
Tumor site: Lower pole of kidney
Tumor size: 2.3 cm
Tumor focality: Unifocal
Macroscopic extent of tumor: Conﬁned to kidney
Histologic type: Papillary carcinoma Type 2
Sarcomatoid features: Absent
Tumor necrosis: Absent
Histologic grade (Fuhrman Nuclear Grade): 3I4
Microscopic tumor extension: Confined to kidney
Margins: Negative (Parenchymal)
Lymphovascular invasion: Not identified
Pathologic staging (pTNM):
Primary tumor: pT1a, 4 cm or less, limited to kidney
Regional lymph nodes: pNX, none sampled
Distant metastasis: pMna ,
Pathologic findings in nonneoplastic kidney: Scattered sclerotic glomeruli and interstitial nephritis
Other tumors and/or tumor-like lesions: small cortical adenoma

AJCC Staging (7th edition) pT1a pNX pMna

Research QC
Tumor T1:

60% tumor nuclei
40% necrosis
0% normal

Normal N1 :
100% nonneoplastic kidney

Research Specimen

Specimen Process Time
Blood draw time:

Plasma frozen time
Serum frozen time

Buffy coat frozen time

Cold ischemia start time'
Formalin fixation start time:
Total cold ischemia time: '

 

Formalin fixation stopped time
Total formalin ﬁxation time
Specimen Weight
Normal

1-115 mg

Tumor

1-174 mg

Specimen Size

Plasma x 3

Serum x 2

Buffy coat x 1

Cryovials x 2
Normal x 1
Tumor x 1

FFPE x2
Normal x 1
Tumor x 1

Study

Patient Consent
Yes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

mg, ' ' A," :: “(ﬁlm v-1, 1' rte/[j
Diagnosis '
Prim-ryTumorSlu ‘ I
HIFAADiscrlPIMV
Prior ' his!

I ousFrlmarv
Dual/Synciron I D u D

use in (chin):
Reviewer initials

Date Reviewed:

